LETAIRIS
What it isSelective endothelin A receptor antagonist; pulmonary arterial hypertension.
Why this oneOnce daily, and combined with tadalafil up front it improves outcomes more than either alone.
What limits itEmbryo-fetal toxicity under a REMS. Peripheral edema and anemia; it is contraindicated in idiopathic pulmonary fibrosis.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Pulmonary arterial hypertension (WHO Group 1) | Adult | 5 mg QD | 5–10 mg QD | 10 mg QD |
Titration May increase at 4-week intervals as needed and tolerated.
Renal No adjustment for mild–moderate impairment; no data in severe impairment.
Hepatic Not recommended in moderate or severe impairment; no data in mild.
Pregnancy Contraindicated—may cause fetal harm, including birth defects and fetal death (teratogenic in animals).
Lactation Unknown whether present in human milk; decide whether to discontinue breastfeeding or the drug.
⚠ BOXED WARNING
Cost, est. cash$10–$300/month
Generic entry2019
Legacy pregnancy categoryUnknown / historical label unavailable
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
